Skip to main content

Long-Acting Reversible Contraception

  • Chapter
  • First Online:
Medicolegal Issues in Obstetrics and Gynaecology
  • 833 Accesses

Abstract

Long-acting Reversible Contraception (LARC) methods are an important treatment option for women requesting contraception. They refer to hormonal and non-hormonal methods that require use less frequently than once every month or every cycle. In contrast to some other commonly used methods, such as oral contraceptives and barriers, the effectiveness of LARC does not depend on daily administration or consistent techniques. Health professionals prescribing LARCS should be familiar with UK Medical Eligibility Criteria (UKMEC) updated in 2016. Reasons for litigations relate to complications of individual methods but causes common to all methods are failure to communicate, adequately consent or ensure confidentiality in prescribing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. NICE. Clinical guidance 30 Long-acting reversible contraception Published 2005; updated 2014. https://www.nice.org.uk/guidance/cg30.

  2. FSRH. Clinical guidance: intrauterine contraception; 2015. file:///C:/Users/cumul/Downloads/ceuguidanceintrauterinecontraception.pdf.

    Google Scholar 

  3. FSRH. Clinical guidance: progestogen-only implants; 2014. file:///C:/Users/cumul/Downloads/cec-ceu-guidance-implants-feb-2014.pdf.

    Google Scholar 

  4. FSRH. Clinical guidance: progestogen-only injectable contraception; 2014. https://www.fsrh.org/standards-and-guidance/documents/cec-ceu-guidance-injectables-dec-2014/.

  5. https://www.fsrh.org/standards-and-guidance/external/ukmec-2016-digital-version/.

  6. FSRH. Clinical standards record keeping; 2014. https://www.fsrh.org/standards-and-guidance/documents/clinical-standards-recordkeeping-july14/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Swati Jha .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mathur, R., Jha, S. (2018). Long-Acting Reversible Contraception. In: Jha, S., Ferriman, E. (eds) Medicolegal Issues in Obstetrics and Gynaecology. Springer, Cham. https://doi.org/10.1007/978-3-319-78683-4_59

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78683-4_59

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78682-7

  • Online ISBN: 978-3-319-78683-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics